AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems for the treatment of atrial
fibrillation, or AF, and systems for the exclusion of the left atrial
appendage, today announced that it will present at the Leerink Swann
2013 Global Healthcare Conference at the Waldorf Astoria Hotel in New
York on Thursday, February 14, 2013. Management is scheduled to present
at 2:30 p.m. Eastern Time.
A live audio webcast and replay of the presentation will be available
for 30 days following the presentation at www.atricure.com.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing,
manufacturing and selling innovative cardiac surgical ablation systems
designed to create precise lesions, or scars, in cardiac, or heart,
tissue for the treatment of atrial fibrillation, or AF, and systems for
the exclusion of the left atrial appendage. For more information, please
visit www.atricure.com.
